S.Korea's Y-Biologics to globalize immuno-oncology therapeutics with French partner
Therapeutics | News | 0 Comment | 06 Jul, 2021
The South Korean biotech company Y-Biologics and the French pharmaceutical group Pierre Fabre have entered int...Read more
Industry-academia collaboration of neuroprotective therapies for glaucoma in China
Therapeutics | News | 0 Comment | 05 Jul, 2021
Arctic Vision, a China-based clinical-stage ophthalmology company focuses on developing innovative therapies for pa...Read more
Scientists propose repurposing anti-malarial drug Mefloquine to fight COVID-19
Therapeutics | News | 0 Comment | 02 Jul, 2021
Japanese scientists are scanning the possibility of using an anti-malarial drug called mefloquine....Read more
Australia invests $180 M in ground-breaking medical research projects
Therapeutics | News | 0 Comment | 02 Jul, 2021
The Australian Government is investing $180 million in ground-breaking medical research projects around Australia to imp...Read more
Australia's BiomeBank to commercialize world-first microbial therapy across APAC
Therapeutics | News | 0 Comment | 01 Jul, 2021
The company behind Australia’s first facility for the manufacturing of microbial therapies has set its sights on g...Read more
Australia goes ahead with DNA screening study to identify cancer risk in young adults
Therapeutics | News | 0 Comment | 01 Jul, 2021
A landmark new DNA screening study to identify cancer risk in young adults will go ahead, after Australia's Monash Unive...Read more
Singapore focuses on immunosuppressive drug-resistant anti-cancer T-cells
Therapeutics | News | 0 Comment | 01 Jul, 2021
Lion TCR, a Singapore biotechnology company, has signed an exclusive worldwide licensing agreement with Duke-NUS Medical...Read more
Singapore to purchase Monoclonal Ab from GSK and Vir Bio to treat COVID-19
Therapeutics | News | 0 Comment | 30 Jun, 2021
GlaxoSmithKline Singapore and Vir Biotechnology on June 30, 2021, announced an agreement with the Government of Singapor...Read more
Researchers at NZ,UK bring world-first weight loss device
Therapeutics | News | 0 Comment | 29 Jun, 2021
University of Otago in New Zealand and UK researchers have developed a world-first weight-loss device to help fight the ...Read more
Gut microbe secreted molecule linked to formation of new nerve cells in adult brain
Therapeutics | News | 0 Comment | 29 Jun, 2021
The billions of microbes living in your gut could play a key role in supporting the formation of new nerve cells in the ...Read more
Singapore develops malaria test kit that delivers results in 30 mins
Therapeutics | News | 0 Comment | 29 Jun, 2021
A team of scientists from Nanyang Technological University, Singapore (NTU Singapore) has developed a test kit for ...Read more
International experts join Microba Life Sciences inaugural IBD Advisory Panel
Therapeutics | News | 0 Comment | 28 Jun, 2021
Precision microbiome science company, Microba Life Sciences, has appointed three respected key opinion leaders in Inflam...Read more
Takara Bio grants BioNTech a commercial patents license of CAR T-cell Therapy drug
Therapeutics | News | 0 Comment | 25 Jun, 2021
Takara Bio Inc. world leader in biotechnology R&D, announces that it has entered into a License and Supply Agre...Read more
New antibiotic from Australia to combat bacterial superbugs enters clinical trials
Therapeutics | News | 0 Comment | 23 Jun, 2021
In a critical step towards addressing an urgent unmet medical need due to infections caused by antibiotic-resistant bact...Read more
Laser Clinics inks deal with Singapore's Privé Clinic
Therapeutics | News | 0 Comment | 22 Jun, 2021
Laser Clinics has expanded its global network by entering a partnership with Singapore-based Privé Clinic. The ne...Read more
Israel discovers promising target for breast cancer and other cancer therapeutics
Therapeutics | News | 0 Comment | 21 Jun, 2021
The Israel's Ben-Gurion University of the Negev and National Institute for Biotechnology in the Negev (NIBN) scientist P...Read more
Singapore suggests doxycycline can help prevent complications of 'Long TB'
Therapeutics | News | 0 Comment | 22 Jun, 2021
In pulmonary tuberculosis (TB), the most common form of active TB disease, the Mycobacterium tuberculosis bacteria cause...Read more
Boehringer Ingelheim invests in a Singapore firm to progress gene therapy for cardiomyopathy
Therapeutics | News | 0 Comment | 18 Jun, 2021
Boehringer Ingelheim has announced its investment in Nuevocor to accelerate the preclinical development of an adeno-asso...Read more